Accessibility
Accessibility statement.
We want everyone to be able to use this website.
Last updated: November 4, 2026
Our goal
NÖK Therapeutics aims for this website to meet the Web Content Accessibility Guidelines (WCAG) 2.2 at Level AA, the widely used international standard for accessible websites, and we work to improve it over time.
Known limitations
Some content linked from this website is produced by others and may not be fully accessible, including SEC filings on the SEC’s EDGAR system and stock quotes on OTC Markets. If you need any of our documents or information in another format, please contact us.
Tell us about a problem
If something on this website is difficult to use, or you need information in a different format, please email pdeschamps@noktx.com. Let us know the page and what went wrong.